Quarter
Charts
🇺🇸US Markets

WAVE LIFE SCIENCES LTD.

WVE

CIK 0001631574 · Quarterly mode · latest period FY2025 (Q2) (ending 2025-06-30) · sourced from SEC EDGAR

At a glance · FY2025 (Q2)

Revenue
$9M
↓-55.8% -$11Mvs FY2024 (Q2)
Gross Profit
$9M
↓-55.8% -$11Mvs FY2024 (Q2)

Quality Score

Quality score

6-dimension fundamental snapshot · latest annual filed values · S&P 500 calibration

Poor
17/100
  • Profitability
    0ROIC -52.9% (10% = solid, 20%+ = moat)
  • Liquidity
    100Current Ratio 6.47 (above 1.5 = solid)
  • Leverage
    0Insufficient data
  • Efficiency
    0Asset Turnover 0.10x (1.0+ = capital-efficient)
  • Growth
    0Revenue YoY -55.8% (10% = solid, 25%+ = elite)
  • Margin Trend
    0Op Margin -606.5% · trend -348.4pts (4Q avg vs prior 4Q)

Calibrated to S&P 500 medians. Each sub-score is computed from a single CFA-grade ratio (Profitability = ROIC, Liquidity = Current Ratio, Leverage = D/E, Efficiency = Asset Turnover, Growth = Revenue YoY, Margin Trend = 4Q operating-margin avg vs prior 4Q). Overall = simple mean.

Capital allocation · trailing 4 quarters

how the company spent its cash
Capex (TTM)
$719K
investment in PP&E
Stock-based comp (TTM)
—
non-cash dilution

Balance sheet · 2025-12-31

latest filed snapshot
Total assets
$638M
everything owned
Total liabilities
$112M
everything owed
Stockholders' equity
$518M
shareholder claim

Recent performance · 48 quarters

Revenue↓-55.8% -$11M
$9M
Net Income↑+12.8% +$8M
$-54M
Free Cash Flow↑+35.2% +$135K
$-248K
Operating Margin↓-428.8pts
-606.5%

Drill down